Presented at ESMO 2026, this poster highlights findings from a One Biosciences–Institut Curie study published in Cancer Discovery in October 2026. Using single-cell profiling, the study uncovers key mechanisms of chemotherapy resistance in ovarian cancer and shows how tumor composition before treatment can predict patient outcomes. These findings pave the way for earlier identification of patients at risk of relapse and more personalized treatment strategies.